HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry
- PMID: 25054717
- PMCID: V体育ios版 - PMC5965695
- DOI: 10.1056/NEJMsa1311707
"VSports手机版" HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry
V体育ios版 - Abstract
Background: Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, unrelated-donor registries of adult volunteers and banked umbilical cord-blood units, such as the Be the Match Registry operated by the National Marrow Donor Program (NMDP), provide potential sources of donors. Our goal in the present study was to measure the likelihood of finding a suitable donor in the U. S. registry VSports手机版. .
Methods: Using human HLA data from the NMDP donor and cord-blood-unit registry, we built population-based genetic models for 21 U. S V体育安卓版. racial and ethnic groups to predict the likelihood of identifying a suitable donor (either an adult donor or a cord-blood unit) for patients in each group. The models incorporated the degree of HLA matching, adult-donor availability (i. e. , ability to donate), and cord-blood-unit cell dose. .
Results: Our models indicated that most candidates for HSCT will have a suitable (HLA-matched or minimally mismatched) adult donor. However, many patients will not have an optimal adult donor--that is, a donor who is matched at high resolution at HLA-A, HLA-B, HLA-C, and HLA-DRB1. The likelihood of finding an optimal donor varies among racial and ethnic groups, with the highest probability among whites of European descent, at 75%, and the lowest probability among blacks of South or Central American descent, at 16%. Likelihoods for other groups are intermediate. Few patients will have an optimal cord-blood unit--that is, one matched at the antigen level at HLA-A and HLA-B and matched at high resolution at HLA-DRB1 V体育ios版. However, cord-blood units mismatched at one or two HLA loci are available for almost all patients younger than 20 years of age and for more than 80% of patients 20 years of age or older, regardless of racial and ethnic background. .
Conclusions: Most patients likely to benefit from HSCT will have a donor. Public investment in donor recruitment and cord-blood banks has expanded access to HSCT. (Funded by the Office of Naval Research, Department of the Navy, and the Health Resources and Services Administration, Department of Health and Human Services. ) VSports最新版本. .
Figures
References
-
- Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26. - VSports最新版本 - PubMed
-
- Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–66. - "V体育2025版" PubMed
-
- Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75. - PubMed
-
- Eapen M, Rubinstein P, Zhang M-J, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–54. - PubMed
-
- Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60. - "VSports注册入口" PMC - PubMed
Publication types
MeSH terms
- V体育ios版 - Actions
- Actions (VSports在线直播)
- V体育平台登录 - Actions
- "VSports手机版" Actions
- "V体育安卓版" Actions
- Actions (V体育官网)
- VSports最新版本 - Actions
- VSports在线直播 - Actions
Substances
Grants and funding
LinkOut - more resources (V体育安卓版)
Full Text Sources
Other Literature Sources
Medical
Research Materials